Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor.
about
Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal TherapyRole of Surgery in locally advanced prostate cancerAssociation and regulation of protein factors of field effect in prostate tissues.Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy
P2860
Q28550782-39B8745F-A487-478D-A9C0-DCA2055261D3Q35796878-B55BBD93-ADD8-4835-AB52-AEA2DAA6A998Q37252687-6C4AFD81-862F-45D3-8365-7A634136B1FEQ41097100-34A093F7-54BE-4864-8CD8-876EBD9E9082Q41436143-DE887204-BCE4-4F20-9E42-B8B018018173Q47329081-54E7D6B9-DDFB-43CE-A2A1-C83B50025123Q58551734-E2538CD5-570D-4E44-8000-5F6FBEFDF59B
P2860
Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neoadjuvant therapy for locali ...... and efficacy within the tumor.
@en
type
label
Neoadjuvant therapy for locali ...... and efficacy within the tumor.
@en
prefLabel
Neoadjuvant therapy for locali ...... and efficacy within the tumor.
@en
P2860
P1433
P1476
Neoadjuvant therapy for locali ...... and efficacy within the tumor.
@en
P2093
David Y Lou
Lawrence Fong
P2860
P304
P356
10.1016/J.UROLONC.2013.12.001
P577
2014-02-01T00:00:00Z